Effectiveness of Biologic and Non-biologic Antirheumatic Drugs on Anaemia Markers in 153,788 Patients with Rheumatoid Arthritis: New Evidence from Real-World Data

To evaluate the impact of treatment with disease-modifying antirheumatic drugs (DMARDs), including IL-6 receptor inhibitor tocilizumab (TCZ), on anaemia markers in patients with rheumatoid arthritis.

Source: Seminars in Arthritis and Rheumatism - August 3, 2017 Category: Rheumatology Authors: Sanjoy K. Paul, Olga Montvida, Jennie H. Best, Sara Gale, Attila Pethoe-Schramm, Khaled Sarsour Source Type: research